A Comprehensive Review of Risk Factor, Mechanism, and Management of Left Ventricular Assist Device-Associated Stroke

Sung-Min Cho1, Pouya Tahsili-Fahadan1,2,3, Ahmet Kilic4

  • 1Division of Neurocritical Care, Departments of Neurology, Neurosurgery, and Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Seminars in Neurology
|April 14, 2021
PubMed

Insights

Left ventricular assist device (LVAD) use is rising, but stroke remains a major risk. This review covers LVAD-associated stroke mechanisms, diagnosis, and management strategies for advanced heart failure patients.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Devices

Background:

  • Left ventricular assist device (LVAD) implantation is increasing for advanced heart failure.
  • Stroke, including ischemic stroke and intracranial hemorrhage, is a primary cause of death and disability in LVAD patients.
  • Current understanding of LVAD-associated stroke mechanisms and optimal management remains limited and controversial.

Purpose of the Study:

  • To review the current knowledge on the pathophysiology and risk factors of stroke in patients with LVADs.
  • To outline the diagnostic approach for identifying stroke in this population.
  • To discuss evidence-based treatment strategies for LVAD-associated stroke.

Main Methods:

  • Literature review of recent studies on LVADs and stroke.
  • Analysis of pathophysiological mechanisms linking LVADs to cerebrovascular events.
  • Synthesis of diagnostic criteria and imaging modalities.
  • Evaluation of current and emerging therapeutic interventions.

Main Results:

  • LVADs are associated with significant risks of both ischemic stroke and intracranial hemorrhage.
  • Risk factors include device type, anticoagulation/antiplatelet strategies, and patient-specific comorbidities.
  • Diagnostic challenges exist due to overlapping symptoms with other LVAD complications.
  • Management strategies involve balancing anticoagulation needs with bleeding risks.

Conclusions:

  • Stroke remains a critical complication of LVAD therapy, impacting patient outcomes.
  • A comprehensive understanding of pathophysiology and risk factors is essential for prevention.
  • Standardized diagnostic and management protocols are needed to improve care for LVAD patients experiencing stroke.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
104
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
4.4K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.2K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
80
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
138
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
2.2K